Discover the metabolic pathway that makes chronic inflammation treatment-resistant-and what leading practitioners are doing about it.
You've tried everything in your toolkit-anti-inflammatory diets, fish oils, curcumin, specialized protocols. Yet some patients simply don't respond. The problem isn't your approach. It's their metabolism.
The delta-6 desaturase enzyme is the rate-limiting step in essential fatty acid metabolism. When impaired, the entire pathway downstream is compromised.
No matter how much omega-3 you give, if delta-6 desaturase isn't functioning, your patient can't convert it to the anti-inflammatory compounds they need.
This creates treatment-resistant inflammation that doesn't respond to conventional approaches-leading to frustrated practitioners and suffering patients.
Delta-6 desaturase (D6D) is the rate-limiting enzyme in the conversion of essential fatty acids to their biologically active metabolites-including GLA, DGLA, and the downstream anti-inflammatory eicosanoids.
When D6D function is impaired-due to genetics, aging, inflammation, or metabolic dysfunction-this pathway becomes blocked. The result: chronic, treatment-resistant inflammation.
The Bottleneck: When delta-6 desaturase is impaired, everything downstream is compromised-regardless of omega-3 intake.
EZtrek is a patented medical food-not a supplement-formulated to deliver the downstream metabolites your patient's body can't produce on its own.
Delivers pre-formed GLA and other downstream metabolites that don't require delta-6 desaturase conversion
Provides the building blocks for anti-inflammatory eicosanoid production
Practitioners report improvements in COPD, chronic pain, and other inflammatory conditions
Full clinical protocols provided upon practitioner registration
A sampling of anti-inflammatory outcomes reported by practitioners using EZtrek® in clinical practice.
"54-yr-old female. History of smoking less than 1 pack a day for 20 years. Diagnosed with COPD 3 years ago. History of Covid-19, which caused damage to lungs. Pneumothorax with collapsed lung that required hospitalization. CT showed significant scarring. Pulmonologist was guarded on any improvement, stating, 'Your case is grim.' She has labored breathing and required 24-hour oxygen... (She has only been on EZtrek® for one month.) She no longer requires oxygen and can now speak and move about without being winded. Nothing else changed other than adding EZtrek®."
"85 years old. Diagnosable diseases are Dementia / Alzheimer's. She is completely immobile, and bed/wheelchair bound... She had rapidly declined since August of this year. Hospice accepted her...she had 6 months or less to live. [With EZtrek®] on December 23rd [4 months later]...they will remove her from the program, which is remarkable and encouraging! The only thing I have done is given her EZtrek®."
"86-year-old patient experienced a significant bilateral orbitofrontal and nasal crushing injury in a fall. Surprisingly had much less nasal injury than expected, including no fractured/comminuted nasal bones or orbital rim/floor fracture. Within 10 days, she demonstrated remarkable resolution of the facial edema and bruising... her overall recovery was unusually expedited and uncomplicated."
"Blood pressure consistently raising until approx. 178/93. Low salt diet stabilized BP @ 160/85. Patient still concerned. Within 30 days of EZtrek® BP lowered near 126/69, which is consistently measured."
"...diagnosed with COPD over 10 years ago...stage 2. I also have a history of pneumonia over the years. I have been taking Albuterol for 10 years plus Symbicort and Prednisone... When I started EZtrek®, within an hour, I could actually feel my lungs opening. I am no longer using my Albuterol. I have more energy and am able to walk without being winded. My blood pressure is normal and pain has reduced completely."
"54-yr-old female with COPD and Covid-related lung damage. Pneumothorax with collapsed lung. CT showed significant scarring. Pulmonologist stated, 'Your case is grim.' Required 24-hour oxygen... After one month on EZtrek®, she no longer requires oxygen and can now speak and move about without being winded. Nothing else changed."
"Blood pressure consistently raising until approx. 178/93. Low salt diet stabilized BP @ 160/85. Within 30 days of EZtrek® BP lowered near 126/69, which is consistently measured."
"20-yr hypertensive; Norvac and Hydrochlorothiazide. BP reduced to 138/90. When EZtrek® was added, after 3 months BP reduced to 126/75."
"Baseline non-contrast CT Agatston Score of 727 on 4/30/2021: Score reduced to 666 on 6/30/2022 [7 months taking EZtrek®]. This translates to an annualized calcified plaque reduction of 14.3%."
"I'm 81 years old with numerous long-term based Lyme / Mold / Genetic inflammatory-related issues. My calcium score is zero (0)..."
"85 years old with Dementia / Alzheimer's. Completely immobile, bed/wheelchair bound. Rapidly declined. Hospice accepted her...6 months or less to live. [4 months on EZtrek®] They will remove her from the program. The only thing I have done is given her EZtrek®."
"I'm curious about EZtrek®, which John has taken since his last appointment. Before his brain injuries, John was a very good writer. Since then, it's been a struggle. He recently wrote 3 separate things to family members, and I was amazed at what he said and how he said it."
"I have a patient taking EZtrek® for 1 month and her brain fog and mental clarity have greatly improved (a result of decreased inflammation of the brain). She has Epstein-Barr, hypothyroid, Lyme, and post-Covid fatigue. Nothing else changed other than adding EZtrek®."
"An elderly woman in her early 90's had been having absence seizure-like activity for many years and would only communicate intermittently... After 1 month of taking EZtrek®, the woman started to speak more spontaneously... She has maintained this improved behavior for many months. The absence seizure-like behavior has stopped."
"...knuckles and the swelling in her proximal interphalangeal and metacarpophalangeal joint of her hands and wrist were reduced by 75% since she has been taking 2 tsp of EZtrek® [morning / evening doses]..."
"I injured my back mid-2021... I started using EZtrek® and within 7 days the muscle inflammation in my back subsided to the point that I moved freely without concern."
"52-yr-old female. History of stage 4 breast cancer for 17 years. Mets to bone and liver. Chemo-induced neuropathy plus 3 years. She has been on EZtrek® for 3 weeks and is having less problems with pain from neuropathy. She reports more energy and feels stronger."
"92-year-old female fell - 3 fractures of hip: similar event 10 years prior. She had been taking EZtrek® for 6 months prior to falling. After 10 days skilled nursing, projected time to home using walker, was 6-8 weeks..."
"As a physician and surgeon personally using an oral preparation of the essential fatty acids per EZtrek® to facilitate treatment of inflammatory conditions (gout)... Since starting EZtrek® I have never had another gout attack."
"I've had the pt. on EZtrek® for 6 months. Since then, she has had no eczema flareups."
"Physician self-patient: I was suffering from total body eczema, some areas worse than others. I did a three-month treatment with EZtrek®, 2 teaspoons per day the first month, 1 daily dose months 2 and 3. My eczema is 90% resolved...."
"86-year-old patient experienced a significant bilateral orbitofrontal and nasal crushing injury in a fall. Surprisingly had much less nasal injury than expected, including no fractured/comminuted nasal bones. Within 10 days, remarkable resolution of facial edema and bruising. Her facial soft tissues and bones were more resilient and the bones also not brittle."
"...2 months ago, had 2 enlarged axillary lymph nodes, a swollen left breast duct, and 30% larger left breast. Today, there is excellent bilaterally equal and normal (healthy) texture of breast tissue, no lymph node enlargement or breast swelling. Only difference is that she has taken EZtrek®...."
"...3 high-sensitivity CRP tests conducted - June value was 1.4, mid-September was 1.8, and late November was 0.7. The 0.7 value [61% decrease] represents approximately 3 1/2 weeks of EZtrek® use."
"History of CHF, likely induced from Lyme, etc. Contributing is MTHFR. High-sensitivity CRP test went from 1.5 to 1.1. The 1.1 value [27% decrease] represents 4 weeks of EZtrek® use."
"(CHF patient) - Homocysteine decrease from 13 to 9 [31% decrease] after 4 weeks of EZtrek® use."
"72 y/o male with elevated PSA of 6.2 in 04/2021. Mold toxicity. 2 months with EZtrek®: rt posterior lesion shrunk from 0.9x0.7 cm to 0.7x0.6cm, a 33% decrease in area."
Feedback from practitioners using EZtrek in their clinical practice
"This is the first intervention I've had for my most stubborn inflammation cases. Patients who weren't responding to anything are finally seeing improvement."
"I have been taking EZtrek® for one month. I have noticed that my energy has increased 30%, and mucous has subsided. I am putting my patients, as well as my children on the product."
"The mechanism is elegant-bypass the impaired enzyme, deliver what the body needs. Why didn't I think of this before?"
"I was skeptical at first, but the science made sense. Now it's a staple in my protocols for chronic inflammatory conditions."
Prefer to discuss EZtrek before registering? Book a complimentary consultation with the creator of EZtrek® to learn how this patented medical food can fit into your practice.
Founder & Formulator - Peskin Pharmaceutical
Creator of EZtrek®Select a time that works for you
Common questions from practitioners
Register as a practitioner in under 60 seconds. No cost, no obligation. Get wholesale access and full clinical protocols.
Register Now